Nanotheranostics 2023; 7(2):202-209. doi:10.7150/ntno.81724 This issue Cite

Review

Nanotheranostics-based Management of Head and Neck Cancer

Vivek P. Chavda1✉, Pankti C. Balar2, Srushti B. Patel3

1. Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad, India.
2. Pharmacy Section, L.M. College of Pharmacy, Ahmedabad, India.
3. Pharmacy Section, Government Pharmacy College, Gandhinagar, India.

Citation:
Chavda VP, Balar PC, Patel SB. Nanotheranostics-based Management of Head and Neck Cancer. Nanotheranostics 2023; 7(2):202-209. doi:10.7150/ntno.81724. https://www.ntno.org/v07p0202.htm
Other styles

File import instruction

Abstract

Graphic abstract

Head and neck cancer is affecting a large sort of population. Many treatments are available on a regular base, but they have their limitations. Diagnosis in the early stage is essential to cope with the disease which is a limitation in the majority of present diagnostic tools. Many of them are invasive methods that lead to patient discomfort. Interventional nanothernostics is an emerging field in the management of Head and Neck cancer. It facilitates both diagnostic and therapeutic approaches. It also helps with the overall management of the disease. This method allows the early and accurate detection of the disease which improvises the chances of recovery. Additionally, it makes sure that the medicine is delivered specifically to increase clinical outcomes and reduce side effects. The use of radiation in addition to the medicine supplied can produce a synergistic effect. It contains several nanoparticles, including silicon and gold nanoparticles. This review paper focuses on the shortcomings of existing therapeutic techniques and how nanotheranostics fills the void.

Keywords: Head and neck cancer, nanotheranostics, treatment, nanoparticles


Citation styles

APA
Chavda, V.P., Balar, P.C., Patel, S.B. (2023). Nanotheranostics-based Management of Head and Neck Cancer. Nanotheranostics, 7(2), 202-209. https://doi.org/10.7150/ntno.81724.

ACS
Chavda, V.P.; Balar, P.C.; Patel, S.B. Nanotheranostics-based Management of Head and Neck Cancer. Nanotheranostics 2023, 7 (2), 202-209. DOI: 10.7150/ntno.81724.

NLM
Chavda VP, Balar PC, Patel SB. Nanotheranostics-based Management of Head and Neck Cancer. Nanotheranostics 2023; 7(2):202-209. doi:10.7150/ntno.81724. https://www.ntno.org/v07p0202.htm

CSE
Chavda VP, Balar PC, Patel SB. 2023. Nanotheranostics-based Management of Head and Neck Cancer. Nanotheranostics. 7(2):202-209.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image